Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy.

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Arch Intern Med. 2001 Jul 23; 161(14):1709-13.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.